Please enable JavaScript to continue using this application.

Compare $ABSI vs $GENB | Chartloom

Compare

$ABSI vs $GENB

Absci Corp · Generate Biomedicines Inc

ABSI

Absci Corp

GENB

Generate Biomedicines Inc

Compare $ABSI vs $GENB

Comparing Absci Corp and Generate Biomedicines Inc

ABSIAbsci Corp

GENBGenerate Biomedicines Inc

ABSIAbsci Corp

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

486.99x

Rev growth (TTM)

-62.3%

YTD performance

181.4%

52W performance

143.1%

FCF yield

-6.4%

GENBGenerate Biomedicines Inc

Market cap

$1.84B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

72.38x

Rev growth (TTM)

—

YTD performance

13.4%

52W performance

13.4%

FCF yield

-4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABSI

GENB

Detailed metrics comparison

ABSI

Absci Corp

GENB

Generate Biomedicines Inc

Market Cap

ABSI$1.72B

GENB$1.84B

Enterprise Value

ABSI$1.61B

GENB$1.71B

Price

ABSI$10.16

GENB$14.34

P/E Ratio

ABSIN/A

GENBN/A

P/S Ratio

ABSI1,098.99x

GENB135.78x

EV/Sales

ABSI1,029.98x

GENB126.16x

EV/EBITDA

ABSI0.00x

GENB0.00x

P/B Ratio

ABSI7.72x

GENB3.85x

P/FCF Ratio

ABSIN/A

GENBN/A

EV/FCF

ABSI-14.73x

GENB-19.17x

PEG Ratio

ABSIN/A

GENBN/A

Forward P/E (NTM)

ABSIN/A

GENBN/A

Forward P/S (NTM)

ABSI486.99x

GENB72.38x

Revenue (TTM)

ABSI$2M

GENB$14M

Revenue Growth (YoY)

ABSI-62.3%

GENBN/A

Forward Rev Growth

ABSI359.4%

GENB12.0%

Gross Margin (TTM)

ABSI0.0%

GENB0.0%

Operating Margin (TTM)

ABSI0.0%

GENB0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

GENB-979.8%

Net Margin (TTM)

ABSI-7756.4%

GENB-1007.9%

FCF Margin (TTM)

ABSI-6994.2%

GENB-658.3%

Net Income (TTM)

ABSI$-121M

GENB$-136M

FCF (TTM)

ABSI$-109M

GENB$-89M

EPS (TTM)

ABSI-$0.77

GENB-$1.06

ROE (TTM)

ABSI-5921.0%

GENB0.0%

ROA (TTM)

ABSI-5231.0%

GENB0.0%

ROIC (TTM)

ABSI-5901.0%

GENB0.0%

Cash

ABSI$108M

GENB$135M

Debt

ABSI$150K

GENB$5M

Net Cash/Debt

ABSI$108M

GENB$130M

Current Ratio (TTM)

ABSI10.63x

GENB8.30x

Quick Ratio (TTM)

ABSI10.26x

GENB8.08x

Debt/Equity (TTM)

ABSI0.00x

GENB0.01x

Debt/Assets (TTM)

ABSI0.0%

GENB0.0%

Interest Coverage (TTM)

ABSIN/A

GENBN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

GENB0.00x

Beta

ABSI2.17

GENB0.38

52W Performance

ABSI143.1%

GENB13.4%

YTD Performance

ABSI181.4%

GENB13.4%

% from 52W High

ABSI-15.7%

GENB-36.7%

% from 52W Low

ABSI353.6%

GENB30.4%

Asset Turnover (TTM)

ABSI0.01x

GENB0.00x

FCF Yield (TTM)

ABSI-6.4%

GENB-4.8%

Earnings Yield (TTM)

ABSI-7.1%

GENB-7.4%

Dividend Yield (TTM)

ABSIN/A

GENBN/A

Rule of 40

ABSI-7,056.5

GENB-658.3

EV/GP/RG

ABSIN/A

GENBN/A

Ticker research

View ABSI research View GENB research

Metric	ABSI Absci Corp	GENB Generate Biomedicines Inc
Market & Valuation
Market Cap	$1.72B	$1.84B
Enterprise Value	$1.61B	$1.71B
Price	$10.16	$14.34
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	135.78x
EV/Sales	1,029.98x	126.16x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.72x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.73x	-19.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	486.99x	72.38x
Revenue & Growth
Revenue (TTM)	$2M	$14M
Revenue Growth (YoY)	-62.3%	N/A
Forward Rev Growth	359.4%	12.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	-979.8%
Net Margin (TTM)	-7756.4%	-1007.9%
FCF Margin (TTM)	-6994.2%	-658.3%
Net Income (TTM)	$-121M	$-136M
FCF (TTM)	$-109M	$-89M
EPS (TTM)	-$0.77	-$1.06
ROE (TTM)	-5921.0%	0.0%
ROA (TTM)	-5231.0%	0.0%
ROIC (TTM)	-5901.0%	0.0%
Financial Health
Cash	$108M	$135M
Debt	$150K	$5M
Net Cash/Debt	$108M	$130M
Current Ratio (TTM)	10.63x	8.30x
Quick Ratio (TTM)	10.26x	8.08x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	0.38
52W Performance	143.1%	13.4%
YTD Performance	181.4%	13.4%
% from 52W High	-15.7%	-36.7%
% from 52W Low	353.6%	30.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-6.4%	-4.8%
Earnings Yield (TTM)	-7.1%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-658.3
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View GENB research

Valuation

P/S Ratio

GENB

135.78x

ABSI

1,098.99x

EV/FCF

GENB

-19.17x

ABSI

-14.73x

Growth & revenue

Revenue Growth TTM

ABSI

-62.3%

Forward Revenue Growth

ABSI

359.4%

GENB

12.0%

Profitability & performance

Gross Margin

ABSI

0.0%

GENB

0.0%

ROE

GENB

0.0%

ABSI

-5921.0%

FCF Yield %

GENB

-4.8%

ABSI

-6.4%

52-Week Performance

ABSI

143.1%

GENB

13.4%

Detailed metrics comparison

ABSI

Absci Corp

GENB

Generate Biomedicines Inc

Market Cap

ABSI$1.72B

GENB$1.84B

Enterprise Value

ABSI$1.61B

GENB$1.71B

Price

ABSI$10.16

GENB$14.34

P/E Ratio

ABSIN/A

GENBN/A

P/S Ratio

ABSI1,098.99x

GENB135.78x

EV/Sales

ABSI1,029.98x

GENB126.16x

EV/EBITDA

ABSI0.00x

GENB0.00x

P/B Ratio

ABSI7.72x

GENB3.85x

P/FCF Ratio

ABSIN/A

GENBN/A

EV/FCF

ABSI-14.73x

GENB-19.17x

PEG Ratio

ABSIN/A

GENBN/A

Forward P/E (NTM)

ABSIN/A

GENBN/A

Forward P/S (NTM)

ABSI486.99x

GENB72.38x

Revenue (TTM)

ABSI$2M

GENB$14M

Revenue Growth (YoY)

ABSI-62.3%

GENBN/A

Forward Rev Growth

ABSI359.4%

GENB12.0%

Gross Margin (TTM)

ABSI0.0%

GENB0.0%

Operating Margin (TTM)

ABSI0.0%

GENB0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

GENB-979.8%

Net Margin (TTM)

ABSI-7756.4%

GENB-1007.9%

FCF Margin (TTM)

ABSI-6994.2%

GENB-658.3%

Net Income (TTM)

ABSI$-121M

GENB$-136M

FCF (TTM)

ABSI$-109M

GENB$-89M

EPS (TTM)

ABSI-$0.77

GENB-$1.06

ROE (TTM)

ABSI-5921.0%

GENB0.0%

ROA (TTM)

ABSI-5231.0%

GENB0.0%

ROIC (TTM)

ABSI-5901.0%

GENB0.0%

Cash

ABSI$108M

GENB$135M

Debt

ABSI$150K

GENB$5M

Net Cash/Debt

ABSI$108M

GENB$130M

Current Ratio (TTM)

ABSI10.63x

GENB8.30x

Quick Ratio (TTM)

ABSI10.26x

GENB8.08x

Debt/Equity (TTM)

ABSI0.00x

GENB0.01x

Debt/Assets (TTM)

ABSI0.0%

GENB0.0%

Interest Coverage (TTM)

ABSIN/A

GENBN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

GENB0.00x

Beta

ABSI2.17

GENB0.38

52W Performance

ABSI143.1%

GENB13.4%

YTD Performance

ABSI181.4%

GENB13.4%

% from 52W High

ABSI-15.7%

GENB-36.7%

% from 52W Low

ABSI353.6%

GENB30.4%

Asset Turnover (TTM)

ABSI0.01x

GENB0.00x

FCF Yield (TTM)

ABSI-6.4%

GENB-4.8%

Earnings Yield (TTM)

ABSI-7.1%

GENB-7.4%

Dividend Yield (TTM)

ABSIN/A

GENBN/A

Rule of 40

ABSI-7,056.5

GENB-658.3

EV/GP/RG

ABSIN/A

GENBN/A

Ticker research

View ABSI research View GENB research

Metric	ABSI Absci Corp	GENB Generate Biomedicines Inc
Market & Valuation
Market Cap	$1.72B	$1.84B
Enterprise Value	$1.61B	$1.71B
Price	$10.16	$14.34
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	135.78x
EV/Sales	1,029.98x	126.16x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.72x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.73x	-19.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	486.99x	72.38x
Revenue & Growth
Revenue (TTM)	$2M	$14M
Revenue Growth (YoY)	-62.3%	N/A
Forward Rev Growth	359.4%	12.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	-979.8%
Net Margin (TTM)	-7756.4%	-1007.9%
FCF Margin (TTM)	-6994.2%	-658.3%
Net Income (TTM)	$-121M	$-136M
FCF (TTM)	$-109M	$-89M
EPS (TTM)	-$0.77	-$1.06
ROE (TTM)	-5921.0%	0.0%
ROA (TTM)	-5231.0%	0.0%
ROIC (TTM)	-5901.0%	0.0%
Financial Health
Cash	$108M	$135M
Debt	$150K	$5M
Net Cash/Debt	$108M	$130M
Current Ratio (TTM)	10.63x	8.30x
Quick Ratio (TTM)	10.26x	8.08x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	0.38
52W Performance	143.1%	13.4%
YTD Performance	181.4%	13.4%
% from 52W High	-15.7%	-36.7%
% from 52W Low	353.6%	30.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-6.4%	-4.8%
Earnings Yield (TTM)	-7.1%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-658.3
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View GENB research